Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • CDSCO releases Risk...

    CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-05-18T14:08:35+05:30  |  Updated On 2021-08-17T12:35:56+05:30

    New Delhi: Through a recent notification, country's central medical device regulator, the Central Drugs Standards Control Organization (CDSCO) has issued a risk classification of newly notified medical devices and IVDs on the basis of their intended use under the provisions of the Medical Devices Rules, 2017.


    Medical devices other than in vitro diagnostic medical devices will be classified on the basis of parameters specified in part I of the first schedule, namely low risk as Class A; low to moderate risk as Class B; moderate to high risk as Class C; and high risk as Class D.






    In vitro diagnostic medical devices will be classified on the basis of parameters specified in part II of the First Schedule, namely low risk as Class A; low to moderate risk as Class B; moderate to high risk as Class C; and high risk as Class D.



    The latest notification issued by CDSCO in this regard reads;




















































































    S. No.Notified CategoryIntended UseRisk Class


    1.
    CT scan EquipmentUse of x-ray source and digitally scanned computer technology to create cross-sectional images of the body.Class C




    2.


    MRI

    Equipment
    It is a medical imaging procedure using radio waves, magnetic fields, and magnetic field gradients to generate images of organs in the body.

    Class C




    3.


    Defibrillators
    It is a device that automatically analyzes the rhythm of heart of cardiac arrest patients and delivers an electrical shock to the heart for restoring the normal rhythm of heart.

    Class C


    4.
    Dialysis MachineIt is used for acute or chronic kidney failure that filters blood to remove excess water and waste products.

    Class C




    5.


    PET

    Equipment
    Intended to detect the gamma radiation and positron emitting radionuclides in the body and produce cross-sectional images which reflect the distribution in the body or individual organs.

    Class C




    6.


    X-Ray Machine
    Use of X-rays to diagnose or treat patients by imaging the internal structure of the body to assess the abnormalities in the body.

    Class C


    7.
    Bone marrow cell separatorIt is a general lab equipment to be used to isolate target cells and cells concentrate from bone and blood.

    Class B


    8.
    NebulizerIt is device used to administer medications in the form of mist to inhale for respiratory disorders.Class C


    9.
    Blood Pressure Monitoring DevicesIt is device used to measure the diastolic and systolic blood pressures.

    Class B


    10.
    Digital ThermometerIt is device used to record the body temperature.Class B


    11.
    *GlucometerIt is a device used to measure the concentration of glucose in blood.Class C


    12.
    Organ Preservative SolutionSolution for hypothermic flushing, storage and transport of organs and to maintain the organ vitality during transplant into human recipients.

    Class C

    * Glucometer will be regulated under IVD category

    Also Read: CDSCO releases Risk classification of Medical Devices and IVDs

    AIDS Blood Pressure Monitoring Devices Bone marrow cell separator CDSCO Central Drugs Standards Control Organization CT scan defibrillators Dialysis Machine digital thermometer hepatitis B hepatitis C HIV IVD medical device Medical Devices Medical Devices Rules MRI nebulizer Organ Preservative Solution PET equipment risk classification xray xray machine 

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      After Abbott, two more Stent makers seek withdrawal of New Gen Stents

      After Abbott, two more Stent makers seek withdrawal of New Gen Stents

      3.36% of about 82,600 drugs samples found to be substandard

      3.36% of about 82,600 drugs samples found to be substandard

      Sterling Biotech Bank Fraud: ED seize assets including business jet, ships, oil rings worth over Rs 9700 crore

      Sterling Biotech Bank Fraud: ED seize assets including business jet, ships, oil rings worth over Rs...

      Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial

      Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial

      Apollo medical centre in Oman granted hospital status

      Apollo medical centre in Oman granted hospital status

      Calcutta HC sets aside Centers decision for strategic sale of Bengal Chemicals

      Calcutta HC sets aside Center's decision for strategic sale of Bengal Chemicals

      Johnson n Johnson ties up with CSIR-IMTECH to Develop Innovative Tuberculosis Treatments

      Johnson n Johnson ties up with CSIR-IMTECH to Develop Innovative Tuberculosis Treatments

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      View All

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 27 May 2022 6:45 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
      verify here.

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
      X
      X